These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
UTAH
|
870496850
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
[ ]
|
Accelerated filer
|
[ ]
|
||
|
Non-accelerated filer
|
[ ]
|
Smaller reporting company
|
[X]
|
||
|
(Do not check if a smaller reporting company)
|
|
Class
|
Outstanding as of November 8, 2011
|
|
|
Common Stock, $0.001 par value
|
35,031,558
|
|
|
Heading
|
Page
|
|
|
PART I — FINANCIAL INFORMATION
|
||
|
Item 1.
|
Financial Statements
|
3
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results
|
|
|
of Operations
|
11
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
13
|
|
Item 4(T).
|
Controls and Procedures
|
13
|
|
PART II — OTHER INFORMATION
|
||
|
Item 1.
|
Legal Proceedings
|
13
|
|
Item 1A.
|
Risk Factors
|
14
|
|
Item 2
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
14
|
|
Item 3.
|
Defaults Upon Senior Securities
|
14
|
|
Item 4.
|
(Removed and Reserved)
|
14
|
|
Item 5.
|
Other Information
|
14
|
|
Item 6.
|
Exhibits
|
14
|
|
Signatures
|
15
|
|
BRAIN TREE INTERNATIONAL, INC.
|
||||||||
|
Development Stage Company
|
||||||||
|
|
||||||||
| September 30, 2011 and June 30, 2011 | ||||||||
|
(UNAUDITED)
|
||||||||
|
September 30,
|
June 30,
|
|||||||
|
2011
|
2011
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ | 3, 775 | $ | 291 | ||||
|
Total Current Assets
|
$ | 3, 775 | $ | 291 | ||||
|
PATENTS-
net
|
$ | 8, 691 | $ | 8, 880 | ||||
|
Total Assets
|
$ | 12 , 466 | $ | 9, 171 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Notes Payable-related party
|
$ | 75,000 | $ | 75,000 | ||||
|
Accrued interest payable
|
$ | 18,700 | $ | 17,132 | ||||
|
Accounts Payable
|
$ | 600 | $ | 2 , 650 | ||||
|
Total Current Liabilities
|
$ | 94 ,300 | $ | 94, 782 | ||||
|
STOCKHOLDERS' DEFICIENCY
|
||||||||
|
Preferred stock
|
||||||||
|
3,000,000 shares authorized at $.001 par value;
|
||||||||
|
none outstanding
|
- | - | ||||||
|
Common stock
|
||||||||
|
47,000,000 shares authorized at $.001 par value;
|
||||||||
|
35,031,558 shares issued and outstanding
|
$ | 35,032 | $ | 35,032 | ||||
|
Additional Paid-in Capital
|
$ | 129,246 | $ | 129,246 | ||||
| Accumulated deficit during development stage | $ | (246,112) | $ | (249,889 | ) | |||
|
Total Stockholders' Deficiency
|
$ | (81,834 | ) | $ | (85,611 | ) | ||
|
Total Liabilities and Stockholders' Deficiency
|
$ | 12,466 | $ | 9,171 | ||||
| BRAIN TREE INTERNATIONAL, INC. | ||||||||||||
| Development Stage Company | ||||||||||||
|
|
||||||||||||
| For the Three Months Ended Sep[tember 30, 2011 and 2010 and the | ||||||||||||
| Period July 26, 1983 (date of inception) to September 30, 2011 | ||||||||||||
|
July 26, 1983
|
||||||||||||
|
Sept 30 2011
|
Sept 30 2010
|
(date of inception) to
|
||||||||||
|
September 30, 2011
|
||||||||||||
|
REVENUES
|
$ | - | $ | - | $ | - | ||||||
|
EXPENSES
|
||||||||||||
|
General and administrative expenses
|
(4,466 | ) | (4,607 | ) | (232,457 | ) | ||||||
|
Amortization
|
(189 | ) | (189 | ) | (4,955 | ) | ||||||
|
NET LOSS FROM OPERATIONS
|
$ | (4,655 | ) | $ | (4,796 | ) | $ | (237,412 | ) | |||
|
Other (Expenses) Income
|
||||||||||||
|
Other Income
|
10,000 | 10,000 | ||||||||||
|
Interest
|
(1,568 | ) | (1,322 | ) | (18,700 | ) | ||||||
|
Total Other Income (Expense)
|
8,432 | (1,322 | ) | (8,700 | ) | |||||||
|
NET INCOME (LOSS)
|
$ | 3,777 | $ | (6,118 | ) | $ | (246,112 | ) | ||||
|
NET LOSS PER COMMON SHARE
|
||||||||||||
|
Basic and diluted
|
$ | - | $ | - | ||||||||
|
WEIGHTED AVERAGE OUTSTANDING SHARES
|
||||||||||||
|
Basic and diluted
|
35,031,558 | 35,031,558 | ||||||||||
| BRAIN TREE INTERNATIONAL, INC. | ||||||||||||
| Development Stage Company | ||||||||||||
|
|
||||||||||||
| For the Three Months Ended September 30, 2011 and 2010 | ||||||||||||
|
and the
Period July 26, 1983 (date of inception)
to September 30, 2011
|
|
July 26, 1983 to
|
||||||||||||
|
|
(inception)
|
|||||||||||
|
Sept 30 2011
|
Sept 30 2010
|
September 30, 2011
|
||||||||||
|
CASH FLOWS FROM
|
||||||||||||
|
OPERATING ACTIVITIES
|
||||||||||||
|
Net Income (Loss)
|
$ | 3, 777 | $ | (6,118 | ) | $ | (246,112 | ) | ||||
|
Adjustments to reconcile net loss to
|
||||||||||||
|
net cash provided by operating activities
|
||||||||||||
|
Amortization
|
189 | 189 | 4,766 | |||||||||
|
Common stock issued for services
|
- | - | 24,726 | |||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Changes in accounts payable
|
(2,050 | ) | 2,536 | 600 | ||||||||
|
Changes in accrued interest payable-related party
|
1,568 | $ | 1,322 | $ | 18,700 | |||||||
|
Net Cash (used in) Operations
|
3,484 | (2,071 | ) | (197,320 | ) | |||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
|
Purchase of patent
|
- | - | (13,646 | ) | ||||||||
|
Net cash (used in) Investing Activities
|
- | - | (13,646 | ) | ||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from notes payable-related party
|
- | - | 75,000 | |||||||||
|
Contributions to capital
|
- | - | 3,698 | |||||||||
|
Proceeds from issuance of common stock
|
- | - | 135,854 | |||||||||
|
Net cash provided by Financing Activities
|
- | - | 214,552 | |||||||||
|
Net Change in Cash
|
3,484 | (2,071 | ) | 3,775 | ||||||||
|
Cash at Beginning of Period
|
291 | 5,338 | - | |||||||||
|
Cash at End of Period
|
$ | 3 , 775 | $ | 3, 267 | $ | 3 , 775 | ||||||
|
|
!
|
the ability to complete development of our technology;
|
|
|
!
|
the ability to secure necessary broadcast license, if required;
|
|
|
!
|
uncertainties involved in the rate of growth of our business and acceptance of our technology;
|
|
|
!
|
volatility of the stock market; and
|
|
Item 1.
|
Legal Proceedings | |
|
There are no material pending legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.
|
||
| Item 1A. | Risk Factors | |
|
This item is not required for a smaller reporting company.
|
||
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
| This Item is not applicable | ||
| Item 3. | Defaults Upon Senior Securities | |
|
This Item is not applicable.
|
||
| Item 4. | (Removed and Reserved) | |
| Item 5. | Other Information | |
| This Item is not applicable | ||
| Item 6. | Exhibits | |
|
Exhibit 31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 31.2
|
Certification of Principal Financial Officer and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 32.1
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Exhibit 32.2
|
Certification of Principal Financial Officer and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
| 101.Ins | XBRL Instance | |
| 101.Sch | XBRL Schema | |
| 101.Cal | XBRL Calculation | |
| 101.Def | XBRL Definition | |
| 101.Lab | XBRL Label | |
| 101.pre | XBRL Presentation | |
| Exhibit 101* |
Interactive Data File
|
|
|
BRAIN TREE INTERNATIONAL, INC.
|
|
|
Date: November 14, 2011
|
By:
/S/ Donna T. Norman
|
|
Donna T. Norman
|
|
|
President, C.E.O. and Director
|
|
|
Date: November 14, 2011
|
By:
/S/ George I. Norman, III
|
|
George I. Norman, III
|
|
|
Vice President and Director
|
|
|
(Principal Financial Officer)
|
|
|
(Principal Accounting Officer)
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|